Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
about
The role of "bone immunological niche" for a new pathogenetic paradigm of osteoporosisOsteonecrosis of the jaw in a patient on Denosumab.Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone lossNovel functions for NFκB: inhibition of bone formationBreast Cancer: Rank Ligand Inhibition.Denosumab for the treatment of bone metastases in breast cancer: evidence and opinionTransient muscle paralysis degrades bone via rapid osteoclastogenesis.RANK-Ligand inhibitor associated osteonecrosis of the jaw.Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding AffinityOPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.Progress in osteoporosis and fracture prevention: focus on postmenopausal women.Osteoclast-targeting small molecules for the treatment of neoplastic bone metastases.The role and efficacy of denosumab in the treatment of osteoporosis: an update.Naringenin inhibits osteoclastogenesis through modulation of helper T cells-secreted IL-4.Bone mineral density and vitamin D in PCOS and hirsutism
P2860
Q26780523-C9177A55-E1F2-45A5-804E-3C2B01D1FF0AQ33891868-D3888170-D2FD-434D-868B-773017964E71Q34440102-A32D4F00-97F0-4184-9AFF-75745B1F6109Q34806538-C8DFC492-212F-4C01-9CB1-E43EA3E60DB9Q35095558-215C6153-1107-4642-A075-1821B9C30596Q35205280-FB018D08-84D2-4F9F-86FD-E8CE45092969Q35787758-3888287F-9633-4D6C-B7F0-0DFC0321192DQ36091639-D2021BD4-7CD3-4A09-9A86-F78F48AA3253Q36835372-A2FA4806-5168-43F6-B4C6-3105C0041A7BQ37199204-BDE0679A-ADDE-454E-89A1-5B6EE00E0545Q37453973-4E7CCE1A-F6EA-496B-98A8-754DCC5013DDQ37578633-F7DDCC72-B9BE-41C0-BCF1-592D99529F09Q37826197-3A38D0C4-2E2D-4307-9129-DB898D81C71FQ47915117-B948DD05-0832-4BB3-9D3B-86BD1A5FCDC6Q59315870-16EEA9D5-3B8D-407C-AD00-7C9942D78104
P2860
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
@en
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
@nl
type
label
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
@en
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
@nl
prefLabel
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
@en
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
@nl
P2860
P921
P356
P1476
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
@en
P2093
Piet Geusens
P2860
P304
P356
10.2147/CIA.S3333
P407
P577
2009-06-09T00:00:00Z